Imugene Limited (IMU.AX)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Paul Edward-Alexander Hopper A.S.i.A, B.A (UNSW), FAICD | Executive Chairman | 316.1k | -- | 1956 |
| Ms. Leslie Chong | CEO, MD & Executive Director | 1.05M | -- | -- |
| Mr. Michael Tonroe ACA, B.Sc., Bsc(Hons), F.C.A., M.A.I.C.D., MAICD | CFO & Company Secretary | 424.28k | -- | 1966 |
| Dr. Nicholas J. Ede B.Sc.(Hons.), Ph.D. | Head of Corporate Development | 489.47k | -- | -- |
| Dr. Monil Shah M.B.A., Pharm.D. | Chief Business Officer | 799.2k | -- | -- |
| Dr. Bradley Glover Ph.D. | Chief Operating Officer | -- | -- | 1969 |
| Ms. Ursula McCurry | Senior Vice President of Clinical Operations | -- | -- | -- |
| Dr. John Byon | Senior Vice President of Clinical Development | -- | -- | -- |
| Dr. Joseph Paul Woodard Jr., M.D. | Chief Medical Officer | -- | -- | -- |
Imugene Limited
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company's HER-Vaxx is in phase 2 study for gastric cancer. It also engages in developing PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling and is in phase I trial; and CF33, a combination of genomic sequences from various vaccinia virus strains to generate potent virus. The company has a collaboration with Arovella Therapeutics Ltd to test the integration of Arovella's CAR19- iNKT cell therapy with the onCARlytics platform, as well as a research collaboration with RenovoRx, Inc. to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. Imugene Limited was incorporated in 1986 and is based in Sydney, Australia.
Corporate Governance
Recent Events
Recent Events Information Not Available